We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial.
- Authors
Griese, Matthias; Costa, Stefano; Linnemann, Rachel W.; Mall, Marcus A.; McKone, Edward F.; Polineni, Deepika; Quon9., Bradley S.; Ringshausen, Felix C.; Taylor-Cousar, Jennifer L.; Withers, Nicholas J.; Moskowitz, Samuel M.; Daines, Cori L.; Quon, Bradley S
- Subjects
CYSTIC fibrosis; GENETIC mutation; QUINOLINE; PYRIDINE; RESEARCH; INDOLE compounds; PHENOLS; COMBINATION drug therapy; CLINICAL trials; HETEROCYCLIC compounds; RESEARCH methodology; ALLELES; MEDICAL cooperation; EVALUATION research; TREATMENT effectiveness; COMPARATIVE studies; RESEARCH funding; MEMBRANE proteins
- Publication
American Journal of Respiratory & Critical Care Medicine, 2021, Vol 203, Issue 3, p381
- ISSN
1073-449X
- Publication type
clinical trial
- DOI
10.1164/rccm.202008-3176LE